Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced ...
Synnovation will receive total cash consideration of up to $3 billion, consisting of $2 billion in upfront cash and up to $1 ...
A Comprehensive Guide to the Fetal Bovine Serum MarketThe biotechnology and pharmaceutical industries are currently ...
Survey of 800+ HCPs Finds Menopause Care is the #1 Area Where Providers Expect the Greatest Improvement in the Next 5 ...
New study supports QuantiFERON-TB Gold Plus use in immunocompromised and other high-risk populations in various ...
The Assistive Technology Market refers to the global industry focused on designing, manufacturing, and distributing devices, ...
OverviewThe Global Medical Holographic Imaging Market is valued at USD 2.2 Billion in 2024 and is projected to reach a value ...
The medical landscape undergoes a rapid transformation as precision becomes the standard of care. At the heart of this ...
A SmartSense survey of 150 U.S.-based hospital CFOs finds 94% of respondents reporting unexpected expenses related to ...
ReNeuron Group Limited, a leading UK biotechnology company, has joined Swansea University’s Institute of Life Science (ILS) in a new strategic research partnership to advance next-generation exosome ...
Clinical research organization uses AI agent-driven knowledge platform built on a unified contextual data layer to identify higher-performing trial sites faster and minimize inclusion of costly ...
March 2026- Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results